mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases

Johnson, S.C., Martinez, F., Bitto, A., González, B., Tazaerslan, C., Cohen, C., Delaval, L., Timsit, J., Knebelmann, B., Terzi, F., Mahal, T., Zhu, Y., Morgan, P.G., Sedensky, M.M., Kaeberlein, M., Legendre, C., Suh, Y., &amp; Canaud, G. (2018). mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases. <em>Kidney International</em>. https://doi.org/10.1016/j.kint.2018.08.038

Johnson SC, Martinez F, Bitto A, González B, Tazaerslan C, Cohen C, et al. mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases. Kidney International. 2018. doi:10.1016/j.kint.2018.08.038.

@article{simon2018mTORin, title = {mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases}, author = {Simon C. Johnson and Frank Martinez and Alessandro Bitto and Brenda González and Cagdas Tazaerslan and Camille Cohen and Laure Delaval and José Timsit and Bertrand Knebelmann and Fabiola Terzi and Tarika Mahal and Yizhou Zhu and Philip G. Morgan and Margaret M. Sedensky and Matt Kaeberlein and Christophe Legendre and Yousin Suh and Guillaume Canaud}, journal = {Kidney International}, year = {2018}, doi = {10.1016/j.kint.2018.08.038}, }